The Efficacy and Safety of Janus Kinase Inhibitors for Patients With COVID-19: A Living Systematic Review and Meta-Analysis

BACKGROUND: Cytokine storm observed in patients with severe Coronavirus Disease 2019 (COVID-19) contributes to poor clinical outcomes and increased mortality. Janus kinases (JAKs) are important mediators in the cytokine storm. Therefore, we conduct a living systematic review and meta-analysis of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xueyang, Shang, Lianhan, Fan, Guohui, Gu, Xiaoying, Xu, Jiuyang, Wang, Yeming, Huang, Lixue, Cao, Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8828941/
https://www.ncbi.nlm.nih.gov/pubmed/35155477
http://dx.doi.org/10.3389/fmed.2021.800492

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8828941/
https://www.ncbi.nlm.nih.gov/pubmed/35155477
http://dx.doi.org/10.3389/fmed.2021.800492

Ejemplares similares